Fuchs Dystrophy clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Descemet Endothelial Thickness Comparison Trial II
Sorry, not yet accepting patients
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Last updated: